Sarcopenia may change how muscle relaxants work during cancer surgery

NCT ID NCT07003061

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 100 adults having gastrointestinal cancer surgery to see if sarcopenia (muscle loss) changes how muscle relaxants work during anesthesia. Patients were grouped based on CT scans showing sarcopenia. The researchers measured how fast the relaxants worked, how deep the muscle relaxation was, and how long it lasted. The goal is to help doctors personalize anesthesia for safer surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help anesthesiologists adjust muscle relaxant doses for patients with sarcopenia, improving safety during surgery.
What could go wrong
This is a small observational study, not a treatment trial. It only measures effects during surgery and does not test any new drug or therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital Clinic of Anesthesiology and Rea

    Ankara, Yenimahalle, 06200, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.